Sunniva Inc., a vertically integrated cannabis company, focuses on the cultivation, production, and distribution of various therapeutic solutions in Canada and the United States.
The last earnings update was 88 days ago.
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
It is not possible to calculate the future cash flow value for
Sunniva. This is due to cash flow or dividend data being
unavailable. The share price is
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
is considered below, and whether this is a fair price.
Price based on past earnings
Sunniva's earnings available for a low price, and how does
this compare to other companies in the same industry?
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Sunniva has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.
Show me the analysis anyway
The future performance of a company is measured in the same way as past
performance, by looking at estimated
and how much profit it is expected to make.
Future estimates come from
professional analysts. Just like forecasting the weather, they don’t always get
Expected Pharmaceuticals industry annual growth in earnings.
Earnings growth vs Low Risk Savings
expected to grow at an
Unable to compare Sunniva's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
Unable to compare Sunniva's earnings growth to the Canada market average as no estimate data is available.
Unable to compare Sunniva's revenue growth to the Canada market average as no estimate data is available.
Unable to determine if Sunniva is high growth as no earnings estimate data is available.
Unable to determine if Sunniva is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
Sunniva's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Management is one of the most important areas of a company. We look at
unreasonable CEO compensation, how long the team and board of directors have
been around for and insider trading.
Dr. Anthony F. Holler, also known as Tony, M.D. is a Co-founder, Chairman of the Board and Chief Executive Officer of Sunniva Inc. Dr. Holler has been the Independent Chairman of CRH Medical Corporation since December 21, 2005. Dr. Holler served as Treasurer at Response Biomedical Corp. until January 12, 2017 and served as its Interim Chief Executive Officer from September 16, 2014 until May 20, 2015. Dr. Holler served as the Chief Executive Officer and President at Inviro Medical. He previously served as the Chief Financial Officer at Response Biomedical Corp. Dr. Holler served as Chairman and Interim Chief Executive Officer of Inviro Medical Devices Limited. Dr. Holler served as Chief Executive Officer at ID Biomedical Corporation from March 27, 2001 to December 2005 and also served as its President. He has been Chairman of Trevali Resources Corp. since October 2010. He served as Non-Executive Chairman of Q2 Gold Resources Inc. and its Director since June 18, 2007. He was Chairman of Inviro Medical since August 2006. He served as the Chairman of Trevali Mining Corporation from October 2010 to February 14, 2014. Dr. Holler served as Non-Executive Chairman of Corriente Resources Inc. from 2003 to June 2010. He served as Vice-Chairman of Response Biomedical Corp. since November 2015 until November 29, 2016. He serves as a Member of Advisory Board of Roadmap Capital Inc. Dr. Holler has been an Independent Director of CRH Medical Corporation since December 21, 2005. He served as a Director of Inviro Medical since April 27, 2006. He served as a Director of Response Biomedical Corp. since March 30, 2006 until November 29, 2016. He served as a Director of Neptune Technologies & Bioressources, Inc. since July 5, 2011 and Corriente Resources Inc. since September 10, 2003. He served as a Director of Vaxent. Dr. Holler has been a Director of Sunniva Inc. since August 11, 2014. Dr. Holler served as a Director of ID Biomedical Corporation since March 04, 1991. He served as an Emergency physician at University Hospital at University of British Columbia. Dr. Holler is a Member of the British Columbia College of Physicians and Surgeons. He holds a Bachelor of Science in 1975 and a Medical Degree in 1979 from the University of British Columbia.
Tony's compensation has been consistent with company performance over the past year, both up more than 20%.
Tony's remuneration is higher than average for companies of similar size in Canada.
Management Team Tenure
Average tenure and age of the
management team in years:
The average tenure for the Sunniva management team is less than 2 years, this suggests a new team.
Chief Operating Officer
President of NHS
Global Controller & Interim CFO
Vice President of Corporate Development
Head of Grower
Board of Directors Tenure
Average tenure and age of the
board of directors in years:
The average tenure for the Sunniva board of directors is less than 3 years, this suggests a new board.
Board of Directors
Who owns this company?
Recent Insider Trading
No 3 month open market individual insider trading information.
Can We See Significant Insider Ownership On The Sunniva Inc. (CNSX:SNN) Share Register?
Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have institutions as shareholders. … Sunniva is not a large company by global standards. … Our analysis of the ownership of the company, below, shows that.
Are Sunniva Inc's (CNSX:SNN) Interest Costs Too High?
Investors are always looking for growth in small-cap stocks like Sunniva Inc (CNSX:SNN), with a market cap of CA$180m. … However, an important fact which most ignore is: how financially healthy is the business?
Should You Be Concerned About Sunniva Inc's (CNSX:SNN) Investors?
I am going to take a deep dive into Sunniva Inc’s (CNSX:SNN) most recent ownership structure, not a frequent subject of discussion among individual investors. … A company's ownership structure is often linked to its share performance in both the long- and short-term. … CNSX:SNN Ownership Summary August 21st 18
Sunniva Inc (CNSX:SNN) is a small-cap stock with a market capitalization of CA$251.58m. … While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they end up ignoring a key aspect, which could be the biggest threat to its existence: its financial health. … Companies operating in the Pharmaceuticals industry,
Sunniva Inc., a vertically integrated cannabis company, focuses on the cultivation, production, and distribution of various therapeutic solutions in Canada and the United States. The company operates through Patient Counselling, Merchandising, and Cultivation & Extraction segments. It offers its products under the Sun Fire, Kyndness, and Herbella brands. The company was formerly known as Sunniva Holdings Corp. and changed its name to Sunniva Inc. in August 2017. Sunniva Inc. was founded in 2014 and is headquartered in Vancouver, Canada.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.